| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |